| DC Field | Value | Language |
|---|
| dc.contributor.author | Fitilev, S. B. | - |
| dc.contributor.author | Vozzhaev, A. V. | - |
| dc.contributor.author | Shkrebniova, I. I. | - |
| dc.contributor.author | Klyuev, D. A. | - |
| dc.contributor.author | Ovaeva, A. O. | - |
| dc.date.accessioned | 2025-11-17T08:50:19Z | - |
| dc.date.available | 2025-11-17T08:50:19Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.citation | Adherence to dual antiplatelet therapy among outpatients after acute myocardial infarction in primary care / S.B. Fitilev, A.V. Vozzhaev, I.I. Shkrebniova [et al.] // Research Results in Pharmacology. - 2025. - Vol.11, №3.-P. 26-36. - Doi: 10.18413/rrpharmacology.11.752. - Refer.: p. 34-36. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/65886 | - |
| dc.description.abstract | This study aimed to assess DAPT adherence in outpatients after MI and evaluate its association with risk of major adverse cardiovascular events | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | acetylsalicylic acid | ru |
| dc.subject | dual antiplatelet therapy | ru |
| dc.subject | myocardial infarction | ru |
| dc.subject | prasugrel | ru |
| dc.subject | primary care | ru |
| dc.subject | ticagrelor | ru |
| dc.title | Adherence to dual antiplatelet therapy among outpatients after acute myocardial infarction in primary care | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 11, № 3
|
